Analysis of Dose—Response Relationships

  • Douglas R. Waud


The discipline of pharmacology is currently going through an important stage in its development. It is at that point where it is appropriate to begin to shift emphasis from what has been essentially a descriptive approach to one tied to a more general framework. The “aspirin through zinc paste” approach has reached the point where, if for no other reason, limitations of memory make it necessary to begin to codify the overall area. In other words, one must begin to focus on the similarities among drugs rather than their differences. This is what general pharmacology is all about.


Dose Ratio Competitive Antagonist Control Curve General Pharmacology Cellular Pharmacology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ariens, E. J., and van Rossum, J. M., 1957, pD x , pA x and pD’ x values in the analysis of pharmacodynamics, Arch. Int. Pharmacodyn. 110:275.PubMedGoogle Scholar
  2. Arunlakshana, O., and Schild, H. O., 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. 14:48.Google Scholar
  3. Berkson, J., 1944, Application of the logistic function to bio-assay, J. Am. Stat. Assoc. 39:357.CrossRefGoogle Scholar
  4. Blinks, J. R., 1967, Evaluation of the cardiac effects of several beta adrenergic blocking agents, Ann. N.Y. Acad. Sci. 144:882.CrossRefGoogle Scholar
  5. Brown, W. E. L., and Hill, A. V., 1923, The oxygen-dissociation curve of blood and its thermo-dynamical basis, Proc. R. Soc. London, Ser. B. 94:297.CrossRefGoogle Scholar
  6. Changeux, J.-P., and Podleski, T. R., 1968, On the excitability and cooperativity of the elec-troplax membrane, Proc. Natl. Acad. Sci. USA 59:944.PubMedCrossRefGoogle Scholar
  7. Changeux, J.-P., Meunier, J. C., and Huchet, M., 1971, Studies on the cholinergic receptor protein of Electrophorus electricas, Mol. Pharmacol. 7:538.Google Scholar
  8. Clark, A. J., 1926, The reaction between acetyl choline and muscle cells, J. Physiol. (London) 61:530.Google Scholar
  9. Cleland, W. W., 1967, The statistical analysis of enzyme kinetic data, Adv. Enzymol. 29:1.PubMedGoogle Scholar
  10. Colquhoun, D., 1973, The relation between classical and cooperative models for drug action, in Drug Receptors (H. P. Rang, ed.), University Park Press, London.Google Scholar
  11. Crank, J., 1957, The Mathematics of Diffusion, Clarendon Press, Oxford.Google Scholar
  12. Dainty, J., 1963, Water relations of plant cells, Adv. Bot. Res. 1:279.CrossRefGoogle Scholar
  13. Evans, C. A., and Waud, D. R., 1973, A pressor effect of high doses of tubocurarine in the ferret, Pharmacology 10:32.PubMedCrossRefGoogle Scholar
  14. del Castillo, J., and Katz, B., 1957, A study of curare with an electrical micromethod, Proc. R. Soc. London, Ser. B. 146:339.CrossRefGoogle Scholar
  15. Fatt, P., 1950, The electromotive action of acetylcholine at the motor end-plate. J. Physiol. (London) 111:408.Google Scholar
  16. Furchgott, R. F., and Bursztyn, P., 1967, Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors, Ann, N. Y. Acad. Sci. 144:882.CrossRefGoogle Scholar
  17. Gaddum, J. H., 1933, Methods of biological assay depending on a quantal response, Med. Res. Counc. (G.B.) Spec. Rep. No. 183.Google Scholar
  18. Gaddum, J. H., Hameed, K. A., Hathway, D. E., and Stephens, F. F., 1955, Quantitative studies of antagonists for 5-hydroxytryptamine, Quart. J. Exp. Physiol. 40:49.PubMedGoogle Scholar
  19. Goldstein, A., Aronow, L., and Kaiman, S. M., 1974, Principles of Drug Action, 2nd edition, Wiley, New York.Google Scholar
  20. Karlin, A., 1967, On the application of “a plausible model” of allosteric proteins to the receptor for acetylcholine, J. Theoret. Biol. 16:306.CrossRefGoogle Scholar
  21. Kasai, M., and Changeux, J.-P., 1971, In vitro excitation of purified membrane fragments by cholinergic agonists, J. Membr. Biol. 6:1.CrossRefGoogle Scholar
  22. Katz, B., and Miledi, R., 1972, The statistical nature of the acetylcholine potential and its molecular components, J. Physiol. 224:665.PubMedGoogle Scholar
  23. Katz, B., and Miledi, R., 1973, The binding of acetylcholine to receptors and its removal from the synaptic cleft, J. Physiol. 231:549.PubMedGoogle Scholar
  24. Kendall, M. G., and Stuart, A., 1961, The Advanced Theory of Statistics, Griffin, London.Google Scholar
  25. Langer, S. Z., and Trendelenburg, U., 1969, The effect of a saturable uptake mechanism on the slopes of dose-response curves produced by a competitive antagonist, J. Pharmacol. Exp. Ther. 167:117.PubMedGoogle Scholar
  26. Narahashi, T., Frazier, D. T., and Yamada, M., 1970, The site of action and active form of local anesthetics. I. Theory and pH experiments with tertiary compounds, J. Pharmacol. Exp. Ther. 171:32.PubMedGoogle Scholar
  27. Parker, R. B., and Waud, D. R., 1971, Pharmacological estimation of drug-receptor dissociation constants. Statistical Evaluation. I. Agonists, J. Pharmacol. Exp. Ther. 177:1.PubMedGoogle Scholar
  28. Rang, H. P., and Ritter, J. M., 1969, A new kind of drug antagonism: Evidence that agonists cause a molecular change in acetylcholine receptors, Mol. Pharmacol. 5:394.PubMedGoogle Scholar
  29. Schild, H. O., 1947, pA, a new scale for the measurement of drug antagonism, Br. J. Pharmacol. 2:189.Google Scholar
  30. Snedecor, G. W., and Cochran, W. G., 1968, Statistical Methods, 6th edition, Iowa State University Press, Ames, Iowa.Google Scholar
  31. Stephenson, R. P., 1956, A modification of receptor theory, Br. J. Pharmacol. 175:213.Google Scholar
  32. Taylor, D. B., Steinborn, J., and Lu, T., 1970, Ion exchange processes at the neuromuscular junction of voluntary muscle, J. Pharmacol. Exp. Ther. 175:213.PubMedGoogle Scholar
  33. Thron, C. D., 1973, On the analysis of pharmacological experiments in terms of an allosteric receptor model, Mol. Pharmacol. 9:1.PubMedGoogle Scholar
  34. Waud, D. R., 1969, On the measurement of the affinity of partial agonists for receptors, J. Pharmacol. Exp. Ther. 170:117.PubMedGoogle Scholar
  35. Waud, D. R., 1973, On biological assays involving quantal responses, J. Pharmacol. Exp. Ther. 183:577.Google Scholar
  36. Waud, D. R., 1974a, Adsorption isotherm vs. ion-exchange models for the drug-receptor reaction. J. Pharmacol. Exp. Ther. 188:520.PubMedGoogle Scholar
  37. Waud, D. R., 1975, Analysis of dose-response curves, in Methods in Pharmacology (E. E. Daniel and D. M. Paton, eds.), Plenum Press, New York.Google Scholar
  38. Waud, D. R., and Parker, R. B., 1971, Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. II. Competitive antagonists, J. Pharmacol. Exp. Ther. 177:13.PubMedGoogle Scholar
  39. Werman, R., 1969, An electrophysiological approach to drug-receptor mechanisms, Comp. Biochem. Physiol. 30:997.PubMedCrossRefGoogle Scholar
  40. Winsor, C. P., 1932, A comparison of certain symmetrical growth curves, J. Wash. Acad. Sci. 22:73.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Douglas R. Waud
    • 1
  1. 1.Department of PharmacologyUniversity of Massachusetts Medical CenterWorcesterUSA

Personalised recommendations